Examining the Effectiveness of Multidisciplinary Care Teams in Improving Outcomes for Breast Cancer Patients
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 73
- 试验地点
- 2
- 主要终点
- Disease-Free Survival (DFS)
研究概览
简要总结
To compare clinical outcomes, patient-reported measures (PROMs), and healthcare utilization between standard care with or without an MDCT in a cohort of women treated for breast cancer.
详细描述
This single-center, prospective interventional trial evaluates the effectiveness of Multidisciplinary Care Teams (MDCTs) in improving outcomes for newly diagnosed breast cancer patients at Hayatabad Medical Complex, Peshawar. The study enrolled 73 participants from May 2021 to April 2024, with follow-up sessions every six months for up to two years.
Participants were randomly assigned to two groups:
Group A (n=37): Received care through MDCTs, which included radiologists, oncologists, and surgeons collaborating to create personalized treatment plans and monitor patient progress.
Group B (n=36): Received standard therapy according to existing institutional protocols.
The study assesses multiple outcomes, including **disease-free survival (DFS), overall survival (OS), recurrence rates, complication rates, patient-reported outcomes (PROs), quality of life (measured via SF-36), and healthcare utilization.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •All female patients, diagnosed with breast cancer
排除标准
- •Previous treatment for breast cancer, concurrent enrollment in another clinical research, and serious medical conditions that could affect study outcomes
结局指标
主要结局
Disease-Free Survival (DFS)
时间窗: 24 months (measured at 6, 12, 18, and 24 months)
Time from the start of treatment to the first occurrence of disease relapse, progression, or death from any cause.
Overall survival
时间窗: 24 months (measured at 6, 12, 18, and 24 months)
Time from the start of treatment until death from any cause.
次要结局
- Recurrence rate(24 months (measured at 6, 12, 18, and 24 months))
- Complication rate(24 months (measured at 6, 12, 18, and 24 months))
研究者
Yousaf Jan
Principal investigator
Hayat Abad Medical Complex, Peshawar.